The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
In other words, the price has increased by $0.00 from its previous closing price. On the day, 1.25 million shares were traded. CABA stock price reached its highest trading level at $2.415 during the session, while it also had its lowest trading level at $2.35.
Ratios:
For a deeper understanding of Cabaletta Bio Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.60 and its Current Ratio is at 3.60. In the meantime, Its Debt-to-Equity ratio is 0.18 whereas as Long-Term Debt/Eq ratio is at 0.03.
On December 20, 2024, Evercore ISI Downgraded its rating to In-line which previously was Outperform and also lowered its target price recommendation from $15 to $6.
Wells Fargo Downgraded its Overweight to Equal Weight on December 19, 2024, whereas the target price for the stock was revised from $12 to $6.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CABA now has a Market Capitalization of 227185856 and an Enterprise Value of 93034880.
Stock Price History:
The Beta on a monthly basis for CABA is 3.23, which has changed by -0.12915128 over the last 52 weeks, in comparison to a change of 0.13613915 over the same period for the S&P500. Over the past 52 weeks, CABA has reached a high of $3.67, while it has fallen to a 52-week low of $0.99. The 50-Day Moving Average of the stock is -6.56%, while the 200-Day Moving Average is calculated to be 25.63%.
Shares Statistics:
For the past three months, CABA has traded an average of 4.18M shares per day and 2277530 over the past ten days. A total of 96.27M shares are outstanding, with a floating share count of 84.43M. Insiders hold about 12.29% of the company’s shares, while institutions hold 64.50% stake in the company. Shares short for CABA as of 1764288000 were 18113270 with a Short Ratio of 4.33, compared to 1761868800 on 12948100. Therefore, it implies a Short% of Shares Outstanding of 18113270 and a Short% of Float of 19.129999.
Earnings Estimates
Currently, 5.0 analysts are dedicated to thoroughly evaluating and rating the performance of Cabaletta Bio Inc (CABA) in the stock market.The consensus estimate for the next quarter is -$0.43, with high estimates of -$0.36 and low estimates of -$0.48.
Analysts are recommending an EPS of between -$1.49 and -$2.46 for the fiscal current year, implying an average EPS of -$2.1. EPS for the following year is -$1.68, with 5.0 analysts recommending between -$1.17 and -$1.91.
